Skip to main content
. 2023 Sep 21;7(22):6801–6811. doi: 10.1182/bloodadvances.2023010668

Figure 1.

Figure 1.

Kaplan-Meier analyses. (A) PFS, (B) DOR, and (C) OS (efficacy analysis set). NR, not reached.